サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1300815

ホルモン補充療法（HRT）の世界市場規模調査＆予測：製品別、投与経路別、疾患タイプ別、地域別分析、2023-2030年

Global Hormone Replacement Therapy Market Size study & Forecast, by Product, by Route of Administration, by Disease Type and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.86円
ホルモン補充療法（HRT）の世界市場規模調査＆予測：製品別、投与経路別、疾患タイプ別、地域別分析、2023-2030年
出版日: 2023年06月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のホルモン補充療法（HRT）市場は、2022年に約212億8,000万米ドルと評価され、予測期間2023-2030年には6.6%以上の健全な成長率で成長すると予測されています。

ホルモン補充療法（HRT）は、ホルモンの不均衡や欠乏に関連する症状を管理または緩和するために、体内のホルモンを補充または置換する医療行為です。一般的には、女性の更年期障害に関連する症状に対処するために使用されるが、その他の症状に対しても処方されることがあります。ホルモン補充療法（HRT）市場は、ホルモン障害の有病率の上昇やホルモン補充療法（HRT）を受ける患者の増加、ドラッグデリバリーシステムの技術開発などの要因により拡大しています。

ホルモン補充療法（HRT）市場は、対象疾患の有病率上昇などの要因により拡大しています。米国甲状腺協会は、米国人の12.0％が人生のいずれかの時点で甲状腺疾患を経験すると推定しています。さらに、2021年には約2,000万人のアメリカ人が甲状腺疾患に罹患すると述べています。さらに、米国国立衛生研究所（NIH）の報告書2020では、米国の閉経後女性の半数近くが少なくとも一度はHRTを使用したことがあることが明らかになっています。また、同報告書によると、アメリカでは毎年130万人の女性が閉経期を迎えると推定されています。このように、様々なホルモン障害の有病率の上昇が市場の成長を促進しています。さらに、研究開発投資の増加とホルモン欠乏症に対する意識の高まりが、市場に有利な機会を生み出しています。しかし、ホルモン補充療法（HRT）は高額であるため、2023～2030年の予測期間を通じて市場の成長は阻害されます。

ホルモン補充療法（HRT）の世界市場調査において考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカが含まれます。北米は、ブランド製品の優位性と地域の疾患有病率の増加により、2022年の市場を独占しました。アジア太平洋地域は、市場参入企業の増加、製品開発のための提携の増加、主要企業の地理的拡大、政府機関や非営利団体の積極的な市場参入などの要因から、予測期間中に大きく成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • ホルモン補充療法（HRT）市場：地域別、2020-2030年
    • ホルモン補充療法（HRT）市場：製品別、2020-2030年
    • ホルモン補充療法（HRT）市場：投与経路別、2020-2030年
    • ホルモン補充療法（HRT）市場：疾患タイプ別、2020～2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 ホルモン補充療法（HRT）の世界市場定義とスコープ

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 ホルモン補充療法（HRT）の世界市場力学

  • ホルモン補充療法（HRT）市場のインパクト分析（2020年～2030年）
    • 市場促進要因
      • ホルモン疾患の有病率の上昇とホルモン補充療法（HRT）を受ける患者数の増加
      • ドラッグデリバリーシステムの技術開発
    • 市場の課題
      • ホルモン補充療法（HRT）の高コスト
    • 市場機会
      • 研究開発投資の増加
      • ホルモン欠乏症に対する意識の高まり

第4章 ホルモン補充療法（HRT）の世界市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 ホルモン補充療法（HRT）の世界市場：製品別

  • 市場スナップショット
  • ホルモン補充療法（HRT）の世界市場：製品別、実績 - ポテンシャル分析
  • ホルモン補充療法（HRT）の世界市場：製品別推定・予測、2020-2030年
  • ホルモン補充療法（HRT）市場、サブセグメント別分析
    • エストロゲン・プロゲステロン補充療法
    • ヒト成長ホルモン（HGH）補充療法
    • 甲状腺ホルモン補充療法（HRT）
    • 男性ホルモン補充療法（HRT）
    • 副甲状腺ホルモン補充療法（HRT）

第6章 ホルモン補充療法（HRT）の世界市場：投与経路別

  • 市場スナップショット
  • ホルモン補充療法（HRT）の世界市場：投与経路別、業績-潜在能力分析
  • ホルモン補充療法（HRT）の世界市場：投与経路別推定・予測、2020-2030年
  • ホルモン補充療法（HRT）市場、サブセグメント別分析
    • 経口
    • 非経口
    • 経皮
    • その他

第7章 ホルモン補充療法（HRT）の世界市場：疾患タイプ別

  • 市場スナップショット
  • ホルモン補充療法（HRT）の世界市場：疾患タイプ別実績-潜在能力分析
  • ホルモン補充療法（HRT）の世界市場：疾患タイプ別推定・予測、2020-2030年
  • ホルモン補充療法（HRT）市場、サブセグメント分析
    • 更年期障害
    • 甲状腺機能低下症
    • 男性性腺機能低下症
    • 成長ホルモン欠乏症
    • 副甲状腺機能低下症

第8章 ホルモン補充療法（HRT）の世界市場、地域分析

  • 主要国
  • 主な新興国
  • ホルモン補充療法（HRT）市場：地域別市場スナップショット
  • 北米
    • 米国
      • 製品の推定・予測、2020-2030年
      • 投与経路の推定・予測、2020-2030年
      • 疾患タイプの推定・予測、2020～2030年
    • カナダ
  • 欧州のホルモン補充療法（HRT）市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のホルモン補充療法（HRT）市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのホルモン補充療法（HRT）市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Eli Lilly and Company
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Bayer AG
    • Noven Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Viatris, Inc.
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche Ltd.
    • ASCEND Therapeutics US, LLC.
    • AbbVie, Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Hormone Replacement Therapy Market, report scope
  • TABLE 2. Global Hormone Replacement Therapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Hormone Replacement Therapy Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Hormone Replacement Therapy Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
  • TABLE 5. Global Hormone Replacement Therapy Market estimates & forecasts by Disease Type 2020-2030 (USD Billion)
  • TABLE 6. Global Hormone Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Hormone Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Hormone Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Hormone Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Hormone Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Hormone Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Hormone Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Hormone Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Hormone Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Hormone Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Hormone Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Hormone Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Hormone Replacement Therapy Market
  • TABLE 71. List of primary sources, used in the study of global Hormone Replacement Therapy Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Hormone Replacement Therapy Market, research methodology
  • FIG 2. Global Hormone Replacement Therapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Hormone Replacement Therapy Market, key trends 2022
  • FIG 5. Global Hormone Replacement Therapy Market, growth prospects 2023-2030
  • FIG 6. Global Hormone Replacement Therapy Market, porters 5 force model
  • FIG 7. Global Hormone Replacement Therapy Market, pest analysis
  • FIG 8. Global Hormone Replacement Therapy Market, value chain analysis
  • FIG 9. Global Hormone Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Hormone Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Hormone Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Hormone Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Hormone Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Hormone Replacement Therapy Market, regional snapshot 2020 & 2030
  • FIG 15. North America Hormone Replacement Therapy Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Hormone Replacement Therapy Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Hormone Replacement Therapy Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Hormone Replacement Therapy Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Hormone Replacement Therapy Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Hormone Replacement Therapy Market is valued at approximately USD 21.28 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.6% over the forecast period 2023-2030. Hormone Replacement Therapy (HRT) is a medical treatment that involves supplementing or replacing hormones in the body to manage or alleviate symptoms associated with hormonal imbalances or deficiencies. It is commonly used to address symptoms related to menopause in women, but it can also be prescribed for other conditions. The Hormone Replacement Therapy Market is expanding because of factors such as the rising prevalence of hormonal disorders and increasing number of patients undergoing hormone replacement therapy and technological developments in drug delivery systems.

The market for hormone replacement treatment (HRT) is expanding as a result of factors including the prevalence of target diseases increasing The American Thyroid Association estimates that 12.0% of Americans would l experience thyroid disease at some point in their lives. Additionally, it stated that about 20.0 million Americans suffer from thyroid disease in year 2021. Furthermore, The National Institutes of Health (NIH) report 2020, revealed that nearly half of all post-menopausal women in the US have used HRT at least once. In addition, the report also states that 1.3 million American women are estimated to reach the menopause period each year in the country. Thus, the rising prevalence of various hormonal disorders is fostering market growth. In addition, increasing R&D investments and rising awareness about hormone deficiency is creating a lucrative opportunity for the market. However, the high cost of Hormone Replacement Therapy stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Hormone Replacement Therapy Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region's increasing disease prevalence. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Eli Lilly and Company
  • Bayer AG
  • Noven Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Viatris, Inc.
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche Ltd.
  • ASCEND Therapeutics US, LLC.
  • AbbVie, Inc.

Recent Developments in the Market:

  • In November 2022, I-MAB Biopharma Co., Ltd., and Jumpcan Pharmaceutical Group partnered to produce and market eftansomatropin alfa (TJ101) in China. The long-acting recombinant human growth hormone TJ101, which is presently undergoing a phase 3 clinical trial, is being used to treat paediatric growth hormone deficiency.
  • In February 2023, Korea's Ministry of Food and Drug Safety announced the approval of Pfizer's NGENLA for the treatment of hormone deficiency.

Global Hormone Replacement Therapy Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Route of Administration, Disease Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Estrogen & Progesterone Replacement Therapy
  • Human Growth Hormone (HGH) Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Replacement Therapy
  • Parathyroid Hormone Replacement

By Route of Administration Type:

  • Oral
  • Parenteral
  • Transdermal
  • Others

By Disease Type:

  • Menopause
  • Hypothyroidism
  • Male hypogonadism
  • Growth hormone deficiency
  • Hypoparathyroidism

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Hormone Replacement Therapy Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Hormone Replacement Therapy Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Hormone Replacement Therapy Market, by Route of Administration, 2020-2030 (USD Billion)
    • 1.2.4. Hormone Replacement Therapy Market, by Disease Type, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Hormone Replacement Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Hormone Replacement Therapy Market Dynamics

  • 3.1. Hormone Replacement Therapy Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of hormonal disorders and increasing number of patients undergoing hormone replacement therapy
      • 3.1.1.2. Technological developments in drug delivery systems
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Hormone Replacement Therapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing R&D investments
      • 3.1.3.2. Rising awareness about hormone deficiency

Chapter 4. Global Hormone Replacement Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Hormone Replacement Therapy Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Hormone Replacement Therapy Market by Product, Performance - Potential Analysis
  • 5.3. Global Hormone Replacement Therapy Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Hormone Replacement Therapy Market, Sub Segment Analysis
    • 5.4.1. Estrogen & Progesterone Replacement Therapy
    • 5.4.2. Human Growth Hormone (HGH) Replacement Therapy
    • 5.4.3. Thyroid Hormone Replacement Therapy
    • 5.4.4. Testosterone Replacement Therapy
    • 5.4.5. Parathyroid Hormone Replacement

Chapter 6. Global Hormone Replacement Therapy Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Hormone Replacement Therapy Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Hormone Replacement Therapy Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
  • 6.4. Hormone Replacement Therapy Market, Sub Segment Analysis
    • 6.4.1. Oral
    • 6.4.2. Parenteral
    • 6.4.3. Transdermal
    • 6.4.4. Others

Chapter 7. Global Hormone Replacement Therapy Market, by Disease Type

  • 7.1. Market Snapshot
  • 7.2. Global Hormone Replacement Therapy Market by Disease Type, Performance - Potential Analysis
  • 7.3. Global Hormone Replacement Therapy Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
  • 7.4. Hormone Replacement Therapy Market, Sub Segment Analysis
    • 7.4.1. Menopause
    • 7.4.2. Hypothyroidism
    • 7.4.3. Male hypogonadism
    • 7.4.4. Growth hormone deficiency
    • 7.4.5. Hypoparathyroidism

Chapter 8. Global Hormone Replacement Therapy Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Hormone Replacement Therapy Market, Regional Market Snapshot
  • 8.4. North America Hormone Replacement Therapy Market
    • 8.4.1. U.S. Hormone Replacement Therapy Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Disease Type breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Hormone Replacement Therapy Market
  • 8.5. Europe Hormone Replacement Therapy Market Snapshot
    • 8.5.1. U.K. Hormone Replacement Therapy Market
    • 8.5.2. Germany Hormone Replacement Therapy Market
    • 8.5.3. France Hormone Replacement Therapy Market
    • 8.5.4. Spain Hormone Replacement Therapy Market
    • 8.5.5. Italy Hormone Replacement Therapy Market
    • 8.5.6. Rest of Europe Hormone Replacement Therapy Market
  • 8.6. Asia-Pacific Hormone Replacement Therapy Market Snapshot
    • 8.6.1. China Hormone Replacement Therapy Market
    • 8.6.2. India Hormone Replacement Therapy Market
    • 8.6.3. Japan Hormone Replacement Therapy Market
    • 8.6.4. Australia Hormone Replacement Therapy Market
    • 8.6.5. South Korea Hormone Replacement Therapy Market
    • 8.6.6. Rest of Asia Pacific Hormone Replacement Therapy Market
  • 8.7. Latin America Hormone Replacement Therapy Market Snapshot
    • 8.7.1. Brazil Hormone Replacement Therapy Market
    • 8.7.2. Mexico Hormone Replacement Therapy Market
  • 8.8. Middle East & Africa Hormone Replacement Therapy Market
    • 8.8.1. Saudi Arabia Hormone Replacement Therapy Market
    • 8.8.2. South Africa Hormone Replacement Therapy Market
    • 8.8.3. Rest of Middle East & Africa Hormone Replacement Therapy Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Eli Lilly and Company
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Bayer AG
    • 9.3.3. Noven Pharmaceuticals, Inc.
    • 9.3.4. Pfizer Inc.
    • 9.3.5. Merck & Co., Inc.
    • 9.3.6. Viatris, Inc.
    • 9.3.7. Novo Nordisk A/S
    • 9.3.8. F. Hoffmann-La Roche Ltd.
    • 9.3.9. ASCEND Therapeutics US, LLC.
    • 9.3.10. AbbVie, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption